Refine
Has Fulltext
- yes (41) (remove)
Is part of the Bibliography
- yes (41)
Year of publication
Document Type
Keywords
- Toxikologie (17)
- DNA damage (9)
- micronuclei (4)
- Micronuclei (3)
- actinomycetes (3)
- oxidative stress (3)
- 5-Azacytidine (2)
- DNA repair (2)
- Diethylstilbestrol (2)
- Electropermeabilization (2)
- Elektrofusion (2)
- Elektroporation (2)
- Zelle (2)
- apoptosis (2)
- cancer risk (2)
- comet assay (2)
- cytokinins (2)
- insulin (2)
- lymphocytes (2)
- (Mouse L-cell) (1)
- 1 (1)
- 2-Dioxetane (1)
- 6-benzylaminopurine (1)
- Alzheimers disease (1)
- Benzefuran dioxetane (1)
- Benzefuran epoxide (1)
- Berenil (1)
- Biologie (1)
- Bromodeoxyuridine labeling (1)
- Calcium (1)
- Cell death and comet assay (1)
- Cell transformation (1)
- Chromosome distribution (1)
- DES (1)
- DNA adduct . Repair endonuclease (1)
- DNA damage response (1)
- DNA transfection (1)
- DNS-Schädigung (1)
- Drug resistance (1)
- Electric Field (1)
- Electrical breakdown (1)
- Ethionine (1)
- Eukaryotic cell (1)
- FPG protein (1)
- Flow cytometry (1)
- Gene Transfer (1)
- Gene transfer (1)
- Hoechst 33258 dye (1)
- Hybridoma (1)
- Kinetochore (1)
- Kinetochores (1)
- L5178Y cells (1)
- Medizin (1)
- Micromonospora (1)
- Micronucleus formation (1)
- Mitosis (1)
- Mutagenicity (1)
- Neomycin Resistance (1)
- Salmonella/microsome assay (1)
- Stable Transformation (1)
- Streptomyces (1)
- TK6 cells (1)
- Toxin (1)
- Transfection (1)
- Unscheduled DNA synthesis (1)
- Volume distribution (1)
- Wachstumskonus (1)
- Zellskelett (1)
- ageing (1)
- anti-protease (1)
- antibacterial/antiviral drug (1)
- antioxidant (1)
- antioxidants (1)
- assay (1)
- association (1)
- bariatric surgery (1)
- base excision repair (incision activity) (1)
- biofilms (1)
- biology (1)
- biomarkers (1)
- blood samples (1)
- calcium (1)
- cell fate (1)
- cell staining (1)
- chronic kidney disease (1)
- co-culture (1)
- cognitive impairment (1)
- contact lens (1)
- continuous (1)
- cyclic dipeptide (1)
- cytochrome P450s (1)
- cytome biomarkers (1)
- cytoskeleton (1)
- cytotoxic (1)
- diabetes (1)
- diagnosis (1)
- dialysis (1)
- diazepinomicin (1)
- etoposide (1)
- fatty liver (1)
- fluorescence recovery after photobleaching (1)
- genomic damage (1)
- genotoxicity (1)
- growth cone (1)
- haematopoietic stem cells (1)
- human biomonitoring (1)
- insulin signaling (1)
- life (1)
- live imaging (1)
- liver (1)
- lovastatin (1)
- mTOR-inhibitor RAD-001 (1)
- maintenance of genomic integrity (1)
- mammalian genomics (1)
- marine sponges (1)
- medicine (1)
- membrane transporters (1)
- micronucleus test (1)
- mitotic disturbance (1)
- mouse lymphoma L5178Y (1)
- mouse models DNA damage (1)
- mutagenicity (1)
- obesity (1)
- peripheral-blood lymphocytes (1)
- poly(ADP-ribosyl)ation (1)
- pyrrolizidine alkaloids (1)
- rat pheochromocytoma cells (1)
- resveratrol (1)
- sex (1)
- sponges (1)
- staphilococci (1)
- streptomyces (1)
- thyroid hormone (1)
- uremic toxins (1)
Institute
- Institut für Pharmakologie und Toxikologie (40)
- Theodor-Boveri-Institut für Biowissenschaften (4)
- Julius-von-Sachs-Institut für Biowissenschaften (3)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Augenklinik und Poliklinik (1)
- Institut für Molekulare Infektionsbiologie (1)
- Institut für Organische Chemie (1)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (1)
- Medizinische Klinik und Poliklinik I (1)
- Medizinische Klinik und Poliklinik II (1)
EU-Project number / Contract (GA) number
- 311932 (2)
The rate limiting step in 5-fluorouracil catabolism is catalyzed by the enzyme dihydropyrimidine dehydrogenase. Since degradation of 5-fluorouracil decreases its efficacy in chemotherapy, the inhibition of its catabolism is a promising tool. We investigated the formation of micronuclei in vitro in mouse L5178Y cells. 5-fluorouracil induced an increase in micronucleus frequency, which could significantly be enhanced by the concurrent application of 2,6-dihydroxypyridine, an inhibitor of dihydropyrimidine dehydrogenase. The 5-fluorouracil concentration necessary to reach maximal genotoxic effects could be reduced to half in the presence of inhibitor. 2,6-Dihydroxypyridine alone and the naturally occuring enzyme substrate uracil did not induce micronucleus formation. Combined application of the chemotherapeutic agent 5-fluorouracil and an inhibitor of its could reduce side-effects by lowering the effective dose of the active drug. With this study we provide further support for the usefulness of this concept.
Neoplastic cell transfonnation induced by estrogens and some other carcinogen& such as benzene appears to involve the induction of mitotic aneuploidy rather than DNA damage and point mutations. As metabolic activation may also play an important roJe in the mechanism of carcinogenesis of these nongenotoxic compounds, we have studied the Interaction of reactive quinone metabolites of various estrogens and of benzene with the major microtubular protein, tubulin, in a cell-free system. Covalent binding of the radioactively labeled metabolites to the a- and 13-subunit of tubulin was found to depend on the structure of the metabolite. When the adducted tubulins were tested in vitro for their ability to polymerize to microtubules, Inhibition of microtubule assembly was obsened in every case, although to varying extents. It is proposed that the fonnation of covalent tubulin adducts may impair the formation of mitotic spindies and thus contribute to chromosomal nondisjunction and aneuploidy induction.
Some chromosomes in transformed rat cells and somatic cell hybrids fail to display the presence of kinetochore proteins as detected by antikinetochore antibodies. Suchchromosomes (K- Chromosomes) may constitute a novel mechanism for the genesis of aneuploidy. Wehave analyzed primary~ immortalized and malignant marnmalian cells for the presence of kinetochore proteins and micronuclei. Our resuJts suggest a correlation of the K- chromosome and micronucleus frequency with the variability in chromosome number. Upon in situ hybridization with the minor satellite and alpha satellite sequences some Kchromosomes showed a signal. This indicates that the observed lack of kinetocbores is not necessarily due to a lack of centromeric DNA. We conclude that dislocated K- chromosomes may become incorporated into micronuclei which are prone to loss. Such events would be associated with the generation of aneuploidy.
The number of bariatric surgeries being performed worldwide has markedly risen. While the improvement in obesity-associated comorbidities after bariatric surgery is well-established, very little is known about its impact on cancer risk. The peripheral lymphocyte micronucleus test is a widely used method for the monitoring of chromosomal damage levels in vivo, and micronucleus frequency positively correlates with cancer risk. Therefore, the aim of this study was to compare the micronucleus frequency before and after bariatric surgery in obese subjects. Peripheral blood mononuclear cells were collected from 45 obese subjects before and at two time-points after bariatric surgery (6 and 12 months) to assess spontaneous micronucleus frequency. Consistent with the increased cancer risk previously shown, bariatric surgery-induced weight loss led to a significant reduction in lymphocyte micronucleus frequency after 12 months. Interestingly, comorbidities such as type 2 diabetes mellitus and metabolic syndrome further seemed to have an impact on the lymphocyte micronucleus frequency. Our findings may indicate a successful reduction of cancer risk in patients following weight loss caused by bariatric surgery.
Diethylstilbestrol alters the morphology and calcium levels of growth cones of PC12 cells in vitro
(1993)
Diethylstilbestrol (DES) is a synthetic estrogen with carcinogenic properties. DES is known to alter cytoskeletal components, including the organization of actin stress fibres in C6 rat glioma cells. ln a test of the hypothesis that DES disrupts actin Filaments of growth cones in neuron-like cells, DES-induced changes in filopodial lengths were quantified in rat pheochromocytoma (PC12) cells in vitro. DES significantly altered growth cone morphology, with collapse of growth cone filopodia and neurite retraction invariably occurring at a concentration of 10 MikroM. At 5 MikroM DES, transient reductions in total filopodiallengths occurred. At DES concentrations of 0.1 nM and 1 nM, reductions in total filopodiallengths occurred in a fraction of growth cones. Evidence exists which shows that growth cone activity and morphology are intimately linked to Ieveis of intracellular, free calcium and that DES increases such levels. Measurements of free intracellular calcium levels by fluorescence microscopy, at times concurrent with the DES-induced reduction in total filopodial lengths, showed that calcium levels were indeed significantly increased by 10 MirkoM DES. Labelling of filamentaus actin (f-actin) with FITC-phalloidin showed that the f-actin distribution in growth cones exposed to DES could not be differentiated from the distribution found in spontaneously retracting growth cones. Tagether with evidence which showed that growth cone motility was not affected, the results are taken to indicate that DES, rather than acting directly on the cytoskeleton, exerts its effects indirectly, by a calcium-induced destabilization of actin filaments in the growth cone.
Patients with chronic kidney disease (CKD) exhibit an increased cancer risk compared to a healthy control population. To be able to estimate the cancer risk of the patients and to assess the impact of interventional therapies thereon, it is of particular interest to measure the patients’ burden of genomic damage. Chromosomal abnormalities, reduced DNA repair, and DNA lesions were found indeed in cells of patients with CKD. Biomarkers for DNA damage measurable in easily accessible cells like peripheral blood lymphocytes are chromosomal aberrations, structural DNA lesions, and oxidatively modified DNA bases. In this review the most common methods quantifying the three parameters mentioned above, the cytokinesis-block micronucleus assay, the comet assay, and the quantification of 8-oxo-7,8-dihydro-2′-deoxyguanosine, are evaluated concerning the feasibility of the analysis and regarding the marker’s potential to predict clinical outcomes.
Wben irradiated at 360 nm, furocoumarins with a hydroperoxide group in a side chain effciently give rise to a type of DNA damage that can best be explained by a photoinduced generation of hydroxyl radicals from the excited pbotosensitizers. The observed DNA damage profiles, i.e. the ratios of single-strand breaks, sites of base loss (AP sites) and base modifications sensitive to fonnamidopyrimidine-DNA glycosylase (FPG protein) and endonuclease m, are similar to the DNA damage profile produced by hydroxyl radicals generated by lonizing radiation or by xanthine and xanthine oxidase in the presence of Fe(III)-EDTA. No such damage is observed with the corresponding furocoumarin alcohols or in the absence of near-UV radiation. The damage caused by the photo-excited hydroperoxides is not influenced by superoxide dismutase (SOD) or catalase or by D2O as solvent. The presence of t-butanol, however, reduces both the formation of single-strand breaks and of base odifications sensitive to FPG protein. The cytotoxicity caused by one of the hydroperoxides in L5178Y mome lymphoma cells is found to be dependent on the near-UV irradiation and to be much higher than that of the corresponding alcohol. Therefore the new type of photoinduced damage occurs inside cells. Intercalating photosensitizers with an attached hydroperoxide group might represent a novel and versatile class of DNA damaging agents, e.g. for phototherapy.
The comet assay is a commonly used method to determine DNA damage and repair activity in many types of samples. In recent years, the use of the comet assay in human biomonitoring became highly attractive due to its various modified versions, which may be useful to determine individual susceptibility in blood samples. However, in human biomonitoring studies, working with large sample numbers that are acquired over an extended time period requires some additional considerations. One of the most important issues is the storage of samples and its effect on the outcome of the comet assay. Another important question is the suitability of different blood preparations. In this study, we analysed the effect of cryopreservation on DNA damage and repair activity in human blood samples. In addition, we investigated the suitability of different blood preparations. The alkaline and FPG as well as two different types of repair comet assay and an in vitro hydrogen peroxide challenge were applied. Our results confirmed that cryopreserved blood preparations are suitable for investigating DNA damage in the alkaline and FPG comet assay in whole blood, buffy coat and PBMCs. Ex vivo hydrogen peroxide challenge yielded its optimal effect in isolated PBMCs. The utilised repair comet assay with either UVC or hydrogen peroxide-induced lesions and an aphidicolin block worked well in fresh PBMCs. Cryopreserved PBMCs could not be used immediately after thawing. However, a 16-h recovery with or without mitotic stimulation enabled the application of the repair comet assay, albeit only in a surviving cell fraction.
Diabetes mellitus (DM) is one of the major current health problems due to lifestyle changes. Before diagnosis and in the early years of disease, insulin blood levels are elevated. However, insulin generates low levels of reactive oxygen species (ROS) which are integral to the regulation of a variety of intracellular signaling pathways, but excess levels of insulin may also lead to DNA oxidation and DNA damage. Three pharmaceutical compounds, resveratrol, lovastatin and the mTOR-inhibitor RAD-001, were investigated due to their known beneficial effects. They showed protective properties against genotoxic damage and significantly reduced ROS after in vitro treatment of cultured cells with insulin. Therefore, the selected pharmaceuticals may be attractive candidates to be considered for support of DM therapy.